Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.8596
+0.0038 (0.44%)
Jun 6, 2025, 2:54 PM - Market open

Citius Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2015 - 2019
Market Capitalization
99010917729658
Upgrade
Market Cap Growth
-91.03%-16.79%-38.51%-40.33%413.63%164.13%
Upgrade
Enterprise Value
10737713018251
Upgrade
Last Close Price
0.8612.5217.1130.2550.7526.00
Upgrade
Forward PE
0.358.71----
Upgrade
PB Ratio
0.121.221.191.712.231.71
Upgrade
P/TBV Ratio
--4.925.194.6711.72
Upgrade
Debt / Equity Ratio
0.020.000.010.010.010.04
Upgrade
Quick Ratio
0.000.094.589.2117.603.38
Upgrade
Current Ratio
0.370.405.959.8418.293.41
Upgrade
Return on Equity (ROE)
-60.53%-47.63%-33.40%-28.48%-27.70%-57.70%
Upgrade
Return on Assets (ROA)
-25.32%-23.83%-21.10%-16.24%-15.80%-27.49%
Upgrade
Return on Capital (ROIC)
-37.09%-31.57%-23.42%-17.52%-17.44%-35.51%
Upgrade
Earnings Yield
-487.03%-43.26%-29.93%-19.03%-7.78%-30.41%
Upgrade
FCF Yield
-266.09%-31.17%-26.73%-16.04%-8.19%-29.35%
Upgrade
Buyback Yield / Dilution
-19.89%-11.16%-3.57%-34.52%-177.28%-94.25%
Upgrade
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q